Dilshar Pharmaceuticals Private Limited
About Dilshar Pharmaceuticals Private Limited
Data last updated:
Dilshar Pharmaceuticals Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 27 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24239AP2017PTC106366. Its GSTIN is 37AAGCD2853F1ZP (Andhra Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ganesh Kumar Patri and Meegada Pavani.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at D.No 7 – 36 1st Floor Nimish Junction Bakkanapalem Road Madhurawada, Visakhapatnam, Andhra Pradesh, India – 530048.
As per the financials filed for FY 2022, the company reported a revenue of ₹21.74 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹2.81 Lakh (net margin 12.9%) and EBITDA of ₹3.87 Lakh (EBITDA margin 17.8%). Revenue has grown at a compounded annual rate (CAGR) of 167% over three years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Dilshar Pharmaceuticals Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressD.No 7 – 36 1st Floor Nimish Junction Bakkanapalem Road Madhurawada, Visakhapatnam, Andhra Pradesh, India – 530048
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Dilshar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Dilshar Pharmaceuticals Private Limited
FY 2023 filings availableDilshar Pharmaceuticals Private Limited reported revenue of ₹21.74 Lakh (up 7% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 167% over three years, including 7% growth in the latest year. EBITDA rose 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹21.74 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.8% | ||||
| Net Profit Margin | 12.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dilshar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dilshar Pharmaceuticals Private Limited
Dilshar Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meegada Pavani | Additional Director | 10 Sep 2022 | 4 Years 1 Months | Current |
| Ganesh Kumar Patri Also directs: QT Med Pharmaceuticals Private Limited | Director | 27 Jul 2017 | 9 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Dilshar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dilshar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dilshar Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAGCD2853F1ZP | Andhra Pradesh | Active | 11 Sep 2017 |
To see the full GST registrations and return filing status of Dilshar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dilshar Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Meegada Pavani was appointed as Additional Director on 10 Sep 2022.
Frequently asked questions
Dilshar Pharmaceuticals is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 27 July 2017 (9+ years old) and is registered under CIN U24239AP2017PTC106366.
Dilshar Pharmaceuticals has 2 current directors:
- Meegada Pavani - Additional Director
- Ganesh Kumar Patri - Director
The latest financial statements of Dilshar Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Dilshar Pharmaceuticals is 37AAGCD2853F1ZP, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Dilshar Pharmaceuticals is U24239AP2017PTC106366. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dilshar Pharmaceuticals was incorporated on 27 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Vijayawada.
Meegada Pavani was appointed as Additional Director on 10 Sep 2022. Sidabatulla Rajeswari ceased to be Director on 10 Sep 2022. Ganesh Kumar Patri was appointed as Director on 27 Jul 2017.
The registered office of Dilshar Pharmaceuticals is at D.No 7 – 36 1st Floor Nimish Junction Bakkanapalem Road Madhurawada, Visakhapatnam, Andhra Pradesh, India – 530048.
Dilshar Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Dilshar Pharmaceuticals is active non-compliant as of 18 July 2026. The company is actively filing with the Registrar of Companies.